Early Access — free while we kick the tires
EdgarHawk

Pacala Mark L

Director

Director
1 filing analyzed · 1 company · Latest 2025-03-28

Companies

Company Buys Sells Direction
Oncology Institute, Inc. TOI 1 0 Net buying

Activity

March 2025
high
Buy
90,562 shares
$94,338
Significance 7/10

Director Pacala buys 90,562 shares of TOI at $1.04 as part of 8-insider buy cluster in 14 days

Pacala Mark L, a director, acquired 90,562 shares at $1.04 on 2025-03-26, increasing his holdings by 67.4% to 225.0K shares. This purchase is part of a cluster pattern with 7 other insiders also buying within the past 14 days. The company is currently unprofitable with a net income of $-16,113,000.00 over its most recent full fiscal year, though it is growing revenue at 21.3% annually and posted $99,901,000.00 in latest quarterly revenue. The coordinated buying activity among multiple insiders at prices substantially below the 52-week high of $1.84 reflects concentrated insider accumulation in a loss-making biotech company, which warrants attention given the simultaneous multi-insider participation pattern.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access